AstraZeneca to buy China's Gracell Biotechnologies in $1.2b deal

FILE PHOTO: The logo for AstraZeneca is seen outside its North America headquarters in Wilmington, Delaware, U.S., March 22, 2021. REUTERS/Rachel Wisniewski/File Photo

Reuters

26 December, 2023

AstraZeneca Gracell Biotechnologies

Printed by Unregistered user on Sat, 12 Jul 2025 04:42:03 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

AstraZeneca to buy China's Gracell Biotechnologies in $1.2b deal

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

US-listed Chinese biopharma firm Gracell to raise $150m in Vivo Capital-led PIPE deal

Temasek-backed Chinese cancer biotech firm Gracell files for $100m US IPO

Read more from Greater China

Shanghai to consider policy responses to stablecoins, cryptocurrencies

China’s Chery, BYD may have to repay subsidies after audit finds improper claims

AstraZeneca to buy China's Gracell Biotechnologies in $1.2b deal

Register now to enjoy 3 free articles per month, or log in to continue reading.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

US-listed Chinese biopharma firm Gracell to raise $150m in Vivo Capital-led PIPE deal

Temasek-backed Chinese cancer biotech firm Gracell files for $100m US IPO

Read more from Greater China

Shanghai to consider policy responses to stablecoins, cryptocurrencies

China’s Chery, BYD may have to repay subsidies after audit finds improper claims

Register now to enjoy 3 free articles per month,
or log in to continue reading.